Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT00488631

Public ClinicalTrials.gov record NCT00488631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of golimumab administered subcutaneously (under the skin) injections in maintenance therapy.

Study identification

NCT ID
NCT00488631
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,228 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Sep 30, 2011
Completion
Jan 31, 2015
Last update posted
Apr 25, 2016

2007 – 2015

United States locations

U.S. sites
96
U.S. states
37
U.S. cities
96
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Little Rock Arkansas
Not listed Anaheim California
Not listed Merced California
Not listed Orange California
Not listed Roseville California
Not listed San Diego California
Not listed Lakewood Colorado
Not listed Littleton Colorado
Not listed Bristol Connecticut
Not listed Newark Delaware
Not listed Boca Raton Florida
Not listed Gainesville Florida
Not listed Hialeah Florida
Not listed Hollywood Florida
Not listed Jacksonville Florida
Not listed Naples Florida
Not listed New Port Richey Florida
Not listed North Miami Beach Florida
Not listed Port Orange Florida
Not listed Tampa Florida
Not listed Winter Park Florida
Not listed Zephyrhills Florida
Not listed Atlanta Georgia
Not listed Decatur Georgia
Not listed Savannah Georgia
Not listed Snellville Georgia
Not listed Arlington Heights Illinois
Not listed Chicago Illinois
Not listed Clive Iowa
Not listed Fort Dodge Iowa
Not listed Pratt Kansas
Not listed Topeka Kansas
Not listed Lexington Kentucky
Not listed Louisville Kentucky
Not listed Monroe Louisiana
Not listed Hagerstown Maryland
Not listed Hollywood Maryland
Not listed Laurel Maryland
Not listed Worcester Massachusetts
Not listed Ann Arbor Michigan
Not listed Dearborn Michigan
Not listed Troy Michigan
Not listed Plymouth Minnesota
Not listed Rochester Minnesota
Not listed Pascagoula Mississippi
Not listed Tupelo Mississippi
Not listed Urbana Missouri
Not listed Las Vegas Nevada
Not listed Lebanon New Hampshire
Not listed Egg Harbor New Jersey
Not listed Great Neck New York
Not listed Huntington New York
Not listed New York New York
Not listed Rochester New York
Not listed Asheville North Carolina
Not listed Boone North Carolina
Not listed Charlotte North Carolina
Not listed Harrisburg North Carolina
Not listed Kinston North Carolina
Not listed Morganton North Carolina
Not listed New Bern North Carolina
Not listed Raleigh North Carolina
Not listed Wilmington North Carolina
Not listed Winston-Salem North Carolina
Not listed Fargo North Dakota
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Colombus Ohio
Not listed Norman Oklahoma
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Portland Oregon
Not listed Limerick Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Charleston South Carolina
Not listed Columbia South Carolina
Not listed Germantown Tennessee
Not listed Nashville Tennessee
Not listed Austin Texas
Not listed Dallas Texas
Not listed Galveston Texas
Not listed Houston Texas
Not listed Logan Utah
Not listed Ogden Utah
Not listed Burlington Vermont
Not listed Chesapeake Virginia
Not listed Christiansburg Virginia
Not listed Fairfax Virginia
Not listed Richmond Virginia
Not listed Bellevue Washington
Not listed Seattle Washington
Not listed Spokane Washington
Not listed Tacoma Washington
Not listed Madison Wisconsin
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 201 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00488631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2016 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00488631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →